GSA Capital Partners’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,757
Closed -$359K 1791
2025
Q4
$359K Sell
7,757
-14,528
-65% -$608K 0.03% 1061
2025
Q3
$780K Buy
+22,285
New +$775K 0.07% 563
2019
Q4
Sell
-23,591
Closed -$271K 1473
2019
Q3
$271K Sell
23,591
-48,211
-67% -$550K 0.04% 991
2019
Q2
$944K Buy
71,802
+7,313
+11% +$97.8K 0.11% 261
2019
Q1
$976K Sell
64,489
-1,948
-3% -$31.2K 0.1% 302
2018
Q4
$1.14M Sell
66,437
-10,463
-14% -$179K 0.13% 165
2018
Q3
$1.13M Buy
76,900
+33,300
+76% +$590K 0.06% 600
2018
Q2
$1.04M Buy
+43,600
New +$1.07M 0.05% 729

Other funds holding COLL